Replimune(US:REPL)2025-09-03 16:30Financial Data and Key Metrics Changes - The meeting reported that at least 70,621,628 shares of common stock were represented, out of a total of 77,807,174 shares outstanding, indicating a quorum for business transactions [6][7]. Business Line Data and Key Metrics Changes - No specific data or metrics related to individual business lines were provided in the meeting. Market Data and Key Metrics Changes - No specific market data or metrics were discussed during the meeting. Company Strategy and Development Direction and Industry Competition - The company proposed the election of several directors and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending 03/31/2026, indicating a focus on governance and compliance [11]. Management's Comments on Operating Environment and Future Outlook - Management did not provide specific comments on the operating environment or future outlook during the meeting. Other Important Information - The proposal to approve an amendment to the Replimune Group, Inc. 2018 Omnibus Incentive Plan was not passed by the stockholders, which may indicate challenges in aligning executive compensation with shareholder interests [13]. Summary of Q&A Session - No questions or answers were recorded during the meeting.